These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Antkiewicz-Michaluk L, Guidotti A, Krueger KE. Mol Pharmacol; 1988 Sep; 34(3):272-8. PubMed ID: 2843747 [Abstract] [Full Text] [Related]
3. Cofractionation of the 17-kD PK 14105 binding site protein with solubilized peripheral-type benzodiazepine binding sites. Mukhin AG, Zhong PY, Krueger KE. Biochem Pharmacol; 1990 Sep 01; 40(5):983-9. PubMed ID: 2167683 [Abstract] [Full Text] [Related]
4. Photoaffinity labeling of peripheral-type benzodiazepine-binding sites. Doble A, Ferris O, Burgevin MC, Menager J, Uzan A, Dubroeucq MC, Renault C, Gueremy C, Le Fur G. Mol Pharmacol; 1987 Jan 01; 31(1):42-9. PubMed ID: 3027525 [Abstract] [Full Text] [Related]
5. Preservation of "peripheral" benzodiazepine receptors: differential effects of freezing on [3H]Ro 5-4864 and [3H]PK 11195 binding. Basile AS, Skolnick P. J Pharmacol Methods; 1987 Apr 01; 17(2):149-56. PubMed ID: 3035290 [Abstract] [Full Text] [Related]
6. Characterization of photoaffinity labeling of benzodiazepine binding sites. Thomas JW, Tallman JF. J Biol Chem; 1981 Oct 10; 256(19):9838-42. PubMed ID: 6268634 [Abstract] [Full Text] [Related]
7. Partial purification and pharmacology of peripheral-type benzodiazepine receptors. Doble A, Burgevin MC, Ménager J, Ferris O, Bégassat F, Renault C, Dubroeucq MC, Guérémy C, Uzan A, Le Fur G. J Recept Res; 1987 Oct 10; 7(1-4):55-70. PubMed ID: 3040984 [Abstract] [Full Text] [Related]
8. Characterization of solubilized "peripheral type" benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative. Benavides J, Menager J, Burgevin MC, Ferris O, Uzan A, Gueremy C, Renault C, Le Fur G. Biochem Pharmacol; 1985 Jan 15; 34(2):167-70. PubMed ID: 2981532 [Abstract] [Full Text] [Related]
9. Photoaffinity labeling of peripheral benzodiazepine receptors in R-3327 Dunning prostatic tumors. Alenfall J, Batra S. Biochem Pharmacol; 1996 Apr 26; 51(8):1009-13. PubMed ID: 8866822 [Abstract] [Full Text] [Related]
10. Immunological studies on the rat peripheral-type benzodiazepine acceptor. Moynagh PN, Bailey CJ, Boyce SJ, Williams DC. Biochem J; 1991 Apr 15; 275 ( Pt 2)(Pt 2):419-25. PubMed ID: 1850987 [Abstract] [Full Text] [Related]
11. Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites. Antkiewicz-Michaluk L, Mukhin AG, Guidotti A, Krueger KE. J Biol Chem; 1988 Nov 25; 263(33):17317-21. PubMed ID: 2846560 [Abstract] [Full Text] [Related]
12. Characterization of ligand binding to mitochondrial benzodiazepine receptors. Hirsch JD, Beyer CF, Malkowitz L, Loullis CC, Blume AJ. Mol Pharmacol; 1989 Jan 25; 35(1):164-72. PubMed ID: 2536464 [Abstract] [Full Text] [Related]
13. Labelling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. Benavides J, Quarteronet D, Imbault F, Malgouris C, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G. J Neurochem; 1983 Dec 25; 41(6):1744-50. PubMed ID: 6315880 [Abstract] [Full Text] [Related]
14. "Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization. Benavides J, Malgouris C, Imbault F, Begassat F, Uzan A, Renault C, Dubroeucq MC, Gueremy C, Le Fur G. Arch Int Pharmacodyn Ther; 1983 Nov 25; 266(1):38-49. PubMed ID: 6667063 [Abstract] [Full Text] [Related]
15. Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative. Dubroeucq MC, Bénavidès J, Doble A, Guilloux F, Allam D, Vaucher N, Bertrand P, Guérémy C, Renault C, Uzan A. Eur J Pharmacol; 1986 Sep 09; 128(3):269-72. PubMed ID: 3024996 [Abstract] [Full Text] [Related]
16. Modification of the peripheral-type benzodiazepine receptor by arachidonate, diethylpyrocarbonate and thiol reagents. Skowroński R, Beaumont K, Fanestil DD. Eur J Pharmacol; 1987 Nov 17; 143(3):305-14. PubMed ID: 2826190 [Abstract] [Full Text] [Related]
17. Identification of a 17-kDa protein associated with the peripheral-type benzodiazepine receptor in vascular and other smooth muscle types. Cox DA, Ellinor PT, Kirley TL, Matlib MA. J Pharmacol Exp Ther; 1991 Aug 17; 258(2):702-9. PubMed ID: 1650838 [Abstract] [Full Text] [Related]
18. Omega 3 (peripheral type benzodiazepine binding) site distribution in the rat immune system: an autoradiographic study with the photoaffinity ligand [3H]PK 14105. Benavides J, Dubois A, Dennis T, Hamel E, Scatton B. J Pharmacol Exp Ther; 1989 Apr 17; 249(1):333-9. PubMed ID: 2540320 [Abstract] [Full Text] [Related]
19. Peripheral-type benzodiazepine receptors in human glioblastomas: pharmacologic characterization and photoaffinity labeling of ligand recognition site. Broaddus WC, Bennett JP. Brain Res; 1990 Jun 04; 518(1-2):199-208. PubMed ID: 2167748 [Abstract] [Full Text] [Related]
20. Characterization and differentiation of peripheral-type benzodiazepine receptors in rat and human prostate. Camins A, Sureda FX, Pubill D, Camarasa J, Escubedo E. Life Sci; 1994 Jun 04; 54(12):759-67. PubMed ID: 8121239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]